| 000 | 00894 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517165120.0 | ||
| 264 | 0 | _c20180911 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(17)30574-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoupakis, Fotios | |
| 245 | 0 | 0 |
_aNew perspectives for TAS-102: TASK successful? _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c09 2017 |
||
| 300 |
_a1139-1141 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aPyrrolidines |
| 650 | 0 | 4 | _aThymine |
| 650 | 0 | 4 | _aTrifluridine |
| 650 | 0 | 4 |
_aUracil _xanalogs & derivatives |
| 700 | 1 | _aLonardi, Sara | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 18 _gno. 9 _gp. 1139-1141 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(17)30574-0 _zAvailable from publisher's website |
| 999 |
_c27418840 _d27418840 |
||